Difference in EGFR expression and mean vascular density in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma. by Fernández, Alejandra et al.
Article
39ISSN Online 0719-2479 - www.joralres.com © 2017
Difference in EGFR expression and mean 
vascular density in normal oral mucosa, 
oral epithelial dysplasia and oral squamous 
cell carcinoma.
Alejandra Fernández,1,2 Javier Fernández,3 Maureen Marshall,1 
René Martínez,1 Sven Niklander1 & Ziyad S. Haidar.2,4
Affiliations: 1Facultad de Odontología, Univer-
sidad Andrés Bello, Chile. 2BioMAT’X, Centro 
de Investigación Biomédica, Facultad de Medi-
cina, Universidad de Los Andes, Chile. 3Facul-
tad de Medicina, Universidad de Chile, Chile. 
4Facultad de Odontología, Universidad de Los 
Andes, Chile.
Corresponding author: Ziyad S. Haidar. 
Universidad de Los Andes, BioMAT´X, Facultad 
de Odontología. Mons. Álvaro del Portillo 
12.455 - Las Condes, Santiago, Chile. Phone: 
(56-2)  26181372 Ext. (56-2)   22149468. E-mail: 
zhaidar@uandes.cl
Abstract: To evaluate the expression of the epidermal growth factor receptor (EGFR) 
and mean vascular density (MVD) in normal oral mucosa (NOM), oral epithelial 
dysplasia (OED) and oral squamous cell carcinoma (OSCC). Material and methods: 
Descriptive case study. Nineteen histological samples diagnosed with NOM, 18 
diagnosed with OED, and 19 with OSCC, were analyzed with immunohistochemistry 
against EGFR and CD31. EGFR expression was evaluated by extent and intensity of 
its expression in normal, dysplastic and neoplastic epithelium. MVD was determined 
through the detection of blood vessels by antibodies against CD31. Results: Extension 
of EGFR expression was highest in OSCC followed by OED and lowest in NOM, 
resulting in significant different between the degrees of extension (p<0.001). Intensity 
of EGFR was similar in NOM, OED and OSCC, without differences in its expression 
(p=0.533). Differences in MVD were found between NOM and OSCC groups 
(p<0.01), and between OED and OSCC groups (p<0.01), with no differences between 
NOM and OED groups (p=0.91). MVD was 21.17±4.98 in NOM, 23.40±5.77 in 
OED and 33.92±8.39 in OSCC. Conclusion: EGFR is expressed in normal, dysplastic 
or neoplastic oral epithelium. However, the extent of its expression is greater as 
malignancy increases. MVD varies according to the diagnosis.
Keywords: Oral cavity, mouth neoplasms, epidermal growth factor receptor, 
pathologic angiogenesis.
INTRODUCTION.
Oral squamous cell carcinoma (OSCC) is the most common malignant 
neoplasm of the oral cavity. 1 An incidence of 500,000 cases per year has been 
reported worldwide.2 OSCC may originate from malignant transformation 
of normal oral mucosa (NOM), and from potentially malignant lesions with 
different degrees of oral epithelial dysplasia (OED).3,4
The genesis of malignant neoplasms, such as OSCC, is a complex process 
involving a breakdown in the regulation pathways of cell division, differentiation, 
death and angiogenesis.2 In this regard, protooncogenes are the physiological 
regulators of proliferation and differentiation of normal cells. Overexpression 
of their mutated counterparts, the oncogenes, plays a key role in carcinogenesis. 
Oncogenes encode, among others, growth factor receptors, which may cause 
uncontrolled cell proliferation. In the case of carcinomas, one key receptor 
is the epidermal growth factor receptor (EGFR).5 Its mutation stimulates 
mitosis and inhibits the apoptosis of neoplastic keratinocytes.6 This receptor is 
expressed both in normal epithelia and in those subjects with pathologies such 
as epithelial dysplasia and carcinomas, where proliferation and differentiation of 
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keratinocytes are altered.7
The complex interaction between neoplastic cells and 
their environment plays a central role in carcinogenesis, as 
environmental changes may facilitate cell growth, invasion 
and metastasis. In the case of OSCC, the microenvironment 
consists of fibroblasts, deposits of the extracellular matrix, 
immune system cells, lymphatic vessels and blood vessels. 
The vascular system supplies oxygen and nutrients to the 
neoplastic cells. In addition, newly formed endothelial cells 
secrete growth factors that act on themselves and on adjacent 
neoplastic cells stimulating their proliferation.8,9 Malignant 
neoplasms induce angiogenesis in a volume up to 2-3 mm³ and 
this value represents the critical distance by which nutrients 
and oxygen can diffuse from the blood vessels.10 Therefore, the 
understanding of angiogenesis is critical to comprehend the 
malignant transformation of epithelial lesions of the oral cavity 
such as OED or OSCC.11,12
CD31 is one of the most important molecular markers 
for evaluating angiogenesis, through the calculation of the 
mean vascular density (MVD). CD31 is a protein present in 
the intercellular junction of endothelial cells in developing 
or already developed blood vessels.13
The aim of this study was to evaluate EGFR expression and 
angiogenesis, through the mean vascular density (MVD), in 
NOM, OED and OSCC.
MATERIALS AND METHODS.
A descriptive case study was designed. The study was 
approved by the Bioethics Committee of Universidad 
Andrés Bello (Folio No 033). Participants were asked to 
sign an informed consent.
Sample collection
Nineteen samples diagnosed with NOM, 18 diagnosed 
with OED, and 19 with OSCC, were collected. Samples 
of NOM were obtained from alveolar ridge mucosa of 
mandibular third molars, from individuals who had 
undergone surgery at the School of Dentistry of Universidad 
Andrés Bello, Viña del Mar, between March and July 2014. 
Samples of OED and OSCC were obtained from paraffin-
embedded samples collected between 2004 and 2012 by 
the Oral Histopathology Service at the School of Dentistry, 
Universidad Andrés Bello, Viña del Mar.
Inclusion and exclusion criteria for sample selection
Inclusion criteria included paraffin-embedded samples with 
enough tissue to obtain three histological section of 4 microns 
each, diagnosed histologically with NOM, OED or OSCC, 
with information regarding the patient’s age, gender and place 
of residence. All age ranges, both sexes and location of the 
lesion in the oral mucosa were included. Exclusion criteria 
consisted of OSCC samples from secondary to metastasis 
stage and histological lamellae with methodological artifacts.
Confirming diagnosis of the samples
To confirm the diagnosis of NOM, OED and OSCC of 
the selected samples, two independent, previously standardi-
zed and calibrated pathologists examined hematoxylin-eosin 
stained sections under Olympus® CX-31 light microscopy 
(Olympus Corporation, Japan). In order to make the diag-
nosis, they considered the criteria proposed by the World 
Health Organization in a double-blind examination.14,15
Immunohistochemistry technique for EGFR
Four micron sections were obtained and mounted on 
xylanized, dewaxed slides and hydrated with distilled water. 
Once hydrated, an antigenic recovery process was performed 
on a steamer using citrate buffer, pH 6. The endogenous 
peroxidase enzyme was then blocked by the application of 
3% v/v hydrogen peroxide. Sections were incubated overnight 
with rabbit anti-EGFR monoclonal antibody (diluted 1: 
100; Ventana Medical System Inc, Tucson Arizona, USA). 
Immunostaining was performed with Envision system 
(Dako, Santa Clara, USA.) according to the manufacturer’s 
instructions. Peroxidase activity was measured by the 
application of the diaminobenzidine chromogen substrate.
Immunohistochemistry technique for CD31
Samples were processed as described for the 
immunohistochemistry of EGFR, but were placed on a poly-
L-lysine coated slide (BioSB, Santa Barbara, USA). These 
sections were incubated with human CD-31 monoclonal 
antibody (Clone JC70A, IgG-1, kappa, Dako, Carpenteria, 
California, USA), diluted 1:40, using the avidin-biotin-
peroxidase complex detection method, at a temperature of 
37°C for 32 minutes. Antigenic recovery was performed at 
95-100°C for 60 minutes with CC1 Standard solution (Cell 
Conditioning Solution-1, Ventana Medical Systems, Inc).
Evaluation of immunostained samples against 
EGFR
Samples were analyzed by two blind calibrated exa-
miners (RM and AF). Immunopositive cells for EGFR 
were those that presented membrane and/or cytoplas-
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Table 1. Distribution of patients by their demographic variables and clinical characteristics.
NOM: normal oral mucosa; OED: oral epithelial dysplasia; OSCC: Oral squamous cell carcinoma.
mic staining, compared with negative and positive 
controls placed on the same slide. The positive control 
consisted of a segment of placenta analyzed with the 
complete immunohistochemical technique for EGFR. 
The negative control was obtained by omission of the 
primary antibody.
The intensity of immunostaining of EGFR in NOM, 
OED and OSCC was qualitatively evaluated and cate-
gorized nominally and arbitrarily into 0: negative im-
munostaining, 1: mild immunostaining, 2: moderate 
immunostaining and 3: marked immunostaining. The 
extent of EGFR immunostaining in the epithelial thic-
kness of NOM, OED and OSCC was categorized as 
0=0%; 1=1 to 25%; 2=26-50%; 3=51-75%; 4=75-100%.
Evaluation of immunostimulated samples against 
CD31
Samples were analyzed by two blind calibrated 
examiners (RM and AF). Any tubular structure coated 
by endothelial cells, individual endothelial cells or in 
islets immunoreactive with the antibody against CD31, 
was considered as a blood vessel. Each sample was 
compared with a positive and negative control in each 
histological slides. The positive control consisted of a 
segment of angiosarcoma stained with the complete 
immunohistochemical technique against CD31. The 
immunonegative control was obtained by omission of 
the primary antibody.
To determine MVD, samples were observed under an 
Olympus® CX-31 light microscope (Olympus Corpora-
tion, Japan), and 3 consecutive hot spots were selected 
that corresponded to the areas of greatest vasculariza-
tion. Each hot spot was photographed at 40x magnifi-
cation, using a 5.1 megapixel Micrometrics® Model 518 
CU digital camera built into the microscope. In each 
image blood vessels were counted (20x objective lens 
and 10x ocular lens, 0.7386 mm2/field).
MVD of each sample was determined using the 
following formula: MVD= (Number of vessels in Hot 
spot 1+ Number of vessels in Hot spot 3 + No of Hot 
spot 3 vessels)/3.
Statistical analysis.
Parametric and non-parametric tests were performed 
according to the nature of the variables. Kruskal-Wallis 
test was used for the analysis of the extent and intensity 
of EGFR according to diagnosis, and Conover-Iman 
post-hoc test was performed to evaluate differences in 
the range averages. The comparison of the mean number 
of vessels according to diagnosis was performed using 
ANOVA, with Bonferroni post hoc test. Student’s 
t-test of independent samples was used to evaluate the 
relationship between EGFR extension and the number 
of vessels. Statistical significance was set at p<0.05. 
Statistical analysis was performed with STATA 12® 
(StataCorpLP, Texas, USA).
RESULTS.
The number of samples included in the study, age and 
gender distribution, for each diagnosis and the totality of 
the samples, are shown in Table 1.
Regarding EGFR expression by extension and intensity 
(Figure 1, Table 2), there was a difference in the extent 
of EGFR expression when comparing each diagnostic 
group (p<0.001). In contrast, no differences were found 
in the intensity of detected EGFR when comparing each 
diagnostic group (p=0.533). On the other hand, when 
analyzing OSCC samples according to their degree of 
 NOM OED OSCC Total sample
Number of samples 19 18 18 56
Median age (years) 22 56 73 55.5
Interquartile range (years) 17 to 25 49 to 65 65 to 82 25 to 65.7
Frequency of females % 73.68 26.32 50 50
Frequency of males % 57.89 42.11 60.71 39.2
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   Extension    Intensity
  2 3 4  1 2 3
  26-50% 51-75% 476-100%  Mild Moderate Marked
 n (%)          n (%)      n (%) n (%) n (%)  n (%)
NOM 1 (5.26) 18  (94.74) - - - -  11 (57.89) 8 (42.11)
OED - - - 14  (77.78) 4  (22.22) 1 (5.56)        12 (55.56) 7 (38.89) 
OSCC - - - 2  (10.53) 17  (89.17) 1 (5.26) 7 (36.84) 11  (57.89)
A: Oral epithelial dysplasia. B: Mild. C: marked. D: Oral squamous cell carcinoma: well differentiated. E: poorly differentiated. F: 10x magnification.
Figure 1. EGFR expression (Brown) in normal oral mucosa. A: Oral epithelial dysplasia. 
A: Mild oral epithelial dysplasia. B: Oral squamous cell carcinoma.  C: and D: 10x magnification.
Figure 2. Expression (Brown) of CD31 showing blood vessels in normal oral mucosa.
Table 2. Comparison of the extent and intensity of EGFR expression in normal oral mucosa, 
oral epithelial dysplasia and oral squamous cell carcinoma.
NOM: normal oral mucosa; OED: oral epithelial dysplasia; OSCC: Oral squamous cell carcinoma.
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differentiation, no differences were found in the intensity 
and extent of EGFR (p=0.704 and p=0.816, respectively).
Regarding MVD (Figure 2), a mean of 21.17±4.98 
vessels were observed in NOM, 23.40±5.77 vessels in 
OED, and 33.92±8.39 vessels in OSCC. The MVD was 
different between NOM and OSCC (p<0.01) and between 
OED and OSCC (p<0.01). However, no differences were 
found between NOM and OED groups (p=0.91).
By relating MVD and the extent of EGFR expression in 
categories 3 and 4, at category 3 of EGFR expression there 
was a mean of 22.79±6.65 vessels, and at category 4 there 
was a mean of 31.55±8.83 vessels (p<0.001). In contrast, no 
differences were found between the number of vessels and 
the EGFR expression (p=0.351).
DISCUSSION.
In the last decade, interest has increased in identifying 
markers that may allow prediction of malignant 
transformation of normal and dysplastic oral epithelium 
into an OSCC.7 This is due to the fact that even in spite 
of advances in scientific knowledge, the histopathological 
diagnosis remains the gold standard for making 
diagnostic and therapeutic decisions, which does not 
allow the prediction of how an oral lesion will evolve.22
It was found that dysplastic lesions of the oral mucosa 
preceded the neoplastic epithelial pathology, which 
coincides with that reported in the literature.23,24 This may 
be because the pathogenesis of both OED and OSCC is 
associated with the same carcinogenic stimuli. However, 
in OSCC, it is associated with a long accumulation of 
its effects.25,26 In the OED group, no gender bias was 
found. However, a higher frequency of OSCC was found 
among women. There is controversy as to which sex is 
most affected. This could be explained by region specific 
habits, such as chewing tobacco or betel nut.23-26,27
Regarding evaluation of EGFR, authors such as Rössle 
et al.,6 and Rajesweri et al.,28 and the authors of this study 
found that in all the samples analyzed, regardless of 
diagnosis, immunostaining of EGFR was always positive. 
However, there were variations in its intensity range. The 
extension of EGFR expression in the NOM group was 
mainly of type 3, reflecting that EGFR was expressed 
more in the basal, suprabasal and spinosum strata, 
disappearing in the superficial stratum, which coincides 
with that described in the literature.28,29 The intensity of 
EGFR was mainly moderate and marked, which coincides 
with Rajesweri et al.28 These results can be explained 
because EGFR is expressed in proliferating epithelial 
cells, such as in the basal stratum, and its expression 
is lost in the superficial or corneous stratum where the 
prevalence of proliferative cells decrease.17 Unlike the 
NOM group, EGFR expression in the OED group in 
some samples involved even the stratum corrneum, 
which may be due to an increase in normal proliferative 
activity, although in an irregular growth pattern.28 Its 
intensity was categorized as “marked”, similarly to that 
of the NOM group, coinciding with the data reported in 
the literature.29 In the OSCC samples, it was found that 
in most cases the extension of EGFR covered the entire 
sample and its intensity was defined as “marked” in a 
high percentage. Rössle et al.,6 and Sarkis et al.,8 reported 
similar findings. From this data, it could be inferred that 
the extent and intensity found for EGFR in carcinomas 
would be revealing a completely uncontrolled growth of 
neoplastic epithelial cells12 and that the extent of EGFR 
expression is higher as malignancy increases.
In the present study, no difference was found between 
intensity and extent of EGFR regarding different degrees 
of OSCC differentiation, coinciding with Ragomir et 
al.30 This fact may indicate that EGFR is not related to 
the degree of differentiation of neoplastic keratinocytes. 
Although Sarkis et al.,12 and Laimer et al.,20 consider 
that both the extent and intensity of EGFR reflect an 
alteration in the regulation of cell proliferation. The 
results of this study suggest that the alteration of cell 
proliferation would be mainly represented by the number 
of cells affected and not by expression intensity.
In the 1970s the growth of tumors was associated 
with angiogenesis for the first time. The most important 
proangiogenic factor is VEGF and its activation may be 
positively regulated by EGFR.31 We found that MVD 
showed a tendency to increase from NOM to OSCC. 
This difference was significant when comparing MVD of 
NOM and OSCC diagnoses and the diagnosis of OED 
and OSCC. This suggests that the angiogenic phenotypic 
change could occur mainly in OSCC rather than OED.9 
Other authors such as Sathyakumar et al.,32 Basnaker et 
al.,33 also studied MVD in samples with NOM, OED 
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and OSCC diagnoses, but used different types of markers 
for blood vessels. However, it should be noted that most 
of the studies, independent of the marker used, coincide 
with the results of this study in relation to the increase in 
MDV in the transition from NOM to OED to OSCC.
To our knowledge, the association between EGFR 
and CD31 expression has not been previously studied 
in oral samples of NOM, OED and OSCC. This study 
demonstrates that when the EGFR extent was greater 
than 50%, independent of its diagnosis, MDV increased. 
These results suggest that EGFR could positively regulate 
angiogenesis, probably via secretion of growth factors. a 
recent publication showed that a decrease in EGFR was 
involved in the decrease of VEGF expression and that 
the activation of EGFR-VEGF favored angiogenesis in 
hepatocellular carcinoma.34
Some consideration should be given to the limitations of 
this study, such as sample size, due to the fact that OSCC 
is a low prevalence pathology1 and the large difference 
in the age range of subjects in the NOM group, when 
compared to subjects in the OED and OSCC groups. 
The latter could be explained by the samples of NOM, 
which were obtained from mucosa that included third 
molars.
CONCLUSION.
EGFR is expressed in normal, dysplastic or neoplastic 
oral epithelium. However, the extent of its expression is 
greater as malignancy increases. MVD varies according to 
the diagnosis.
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